Atlanta-based Biolog-id LLC said the University of Cincinnati’s Hoxworth Blood Center is expanding its deployment of the company’s advanced solutions to support the implementation of the U.S. FDA’s new platelet guidelines.

Chicago-based unit of Biomérieux Inc., of Marcy-l'Étoile, France, said that it has received the first COVID-19-related certificate of validation for its Veripro SARS-CoV-2 Environmental Assay from the AOAC International’s Emergency Response Validation program.

Brattle Street Investment Corp. has changed its name to Salona Global Medical Device Corp., which is based in San Diego, and its stock ticker symbol has been changed from BRTL to SGMD. It also has closed its previously announced concurrent‎ financing for $5,550,258, representing an oversubscription of $568,981. Upon relisting, currently subject to TSX Venture Exchange, Salona Global will be an acquisition-oriented, U.S.-based medical device company with the goal of listing on a U.S. stock exchange. Upon closing of the transaction, Salona Global will be operating in the recovery science market, including postoperative pain, wound care and other markets serving the aging population in developed economies. Salona Global’s emphasis will include products for those older than 65. The company and its wholly owned British Columbia ‎incorporated subsidiary also completed the previously reported private placement of subscription receipts. The net proceeds will be used to increase cash to help Salona Global execute its plan to acquire medical device companies in the U.S. and expand its product reach globally, as well as for general working capital.

Change Healthcare, of Nashville, Tenn., reported the introduction of its first cloud-based medical tools for radiologists and other specialties along with its roadmap to help health care organizations begin their migration of medical imaging to the cloud.

Cobham Advanced Electronic Solutions, of Arlington, Va., received a $48 million contract to support the medical imaging industry, providing application-specific integrated circuits and product support.

Salt Lake City-based Co-Diagnostics Inc. said that it has completed principal design work for a polymerase chain reaction test that would allow researchers to identify certain mutations in a newly detected variant of SARS-CoV-2 known as VUI 202012/01.

Koblenz, Germany-based Compugroup Medical SE & Co. KGaA has acquired Emd Inc., an Austin, Texas-based corporation. Phoenix-based Compugroup Holding USA Inc. successfully completed the reverse triangular merger. The acquisition price is about $240 million. The acquisition price will be financed from cash, current cash flow, and a temporary drawdown of the revolving multiyear loans in the low double-digit million-euro range.

New York-based Dariohealth Corp. said that the company has entered an agreement to provide its remote patient monitoring solution to Presbyterian Medical Services, one of the largest integrated healthcare systems in New Mexico, effective Jan. 1, 2021.

Basking Ridge, N.J.-based Electrocore Inc. has entered an agreement with Pro Medical Baltic UAB, of Kaunas, Lithuania, whereby the latter will serve as the exclusive distributor of Gammacore Sapphire noninvasive vagus nerve stimulation to patients suffering from primary headache disorders in Lithuania, Latvia, Belarus, Kazakhstan and Ukraine.

New York-based Grove Biomedical reported the launch of Canopy, a modular ecosystem of transparent, reusable respirators developed in collaboration with clinicians and hospital administrators.

Irvine, Calif.-based Hancock Jaffe Laboratories Inc. said it has received formal notification from the Nasdaq Hearings Panel that it has evidenced full compliance with the minimum bid price requirement and all other applicable criteria for continued listing. All compliance matters have been resolved, and that the panel has closed the company’s compliance file.

Miami-based Heru Inc., a Bascom Palmer Eye Institute medical technology company developing a next-generation artificial intelligence (AI) platform for vision diagnostics and augmentation, reported its class I listing with the U.S. FDA for its cloud-based augmented/virtual reality platform’s first diagnostic application for Visual Field Exams. Additionally, it reported the close of a $2.7 million seed investment round June 15. The funding facilitates the completion of current clinical trials for FDA clearance of Heru’s wearable AI platform and subsequent commercialization efforts. The funding was led by Maurice Ferre, Frederic Moll and a consortium of investors.

Honeywell International Inc., of Charlotte, N.C., has agreed to acquire Hamilton, N.J.-based Sparta Systems Inc. for $1.3 billion in all cash transaction from New Mountain Capital. Sparta’s artificial intelligence-enabled software as a service (SaaS) quality management software offering will combine with Honeywell Forge, an enterprise performance solution, and the Experion Process Knowledge System to enhance value for life science customers in the U.S., Europe and Asia. Honeywell said it will leverage Sparta’s technologies to drive global growth and expand into new market segments, including highly regulated verticals, that require advanced process technologies. Sparta’s technologies are also expected to accelerate Honeywell’s efforts to further penetrate the life sciences market and strengthen Honeywell’s portfolio of advanced automation and process control technologies. Sparta employs about 250 people globally and serves more than 400 customers, including 42 of the world’s top 50 pharma companies and 33 of the top 50 medical device companies. The acquisition is expected to close by the end of the first quarter of 2021, pending regulatory approvals.

New York-based Hyro, a developer of plug-and-play conversational artificial intelligence solutions, said it has begun equipping U.S. hospitals and other medical providers with AI-powered virtual assistants to aid in handling mass scheduling of COVID-19 vaccinations, while stymying the spread of misinformation about the safety and efficacy of the new vaccines.

Osang Healthcare Co. Ltd. (OHC), of Seoul, South Korea, and San Diego-based Nexus Dx Inc. are partnering for the U.S. manufacturing of OHC’s Genefinder COVID-19 Plus Realamp kit. The test is designed to detect SARS-CoV-2 through a gene-based reverse transcription reaction and real-time polymerase chain reaction testing process that can provide 96 test results in just over two hours.

New York-based Purlab LLC said that its at-home saliva-based COVID-19 testing solution for individuals, companies and schools has launched. It was developed and run in collaboration with Rutgers University RUCDR Infinite Biologics lab.

Quest Diagnostics Inc., of Secaucus, N.J., and Edison, N.J.-based Hackensack Meridian Health are teaming up to deliver high-value, innovative laboratory services. Under the long-term agreement, Quest will manage laboratory operations and platform reference testing for 11 Hackensack Meridian Health hospitals. Financial terms of the arrangement were not disclosed.

Amsterdam-based Royal Philips NV and Biointellisense Inc., of Golden, Colo., said they have been selected by the U.S. Army Medical Research and Development Command to receive nearly $2.8 million from the U.S. Department of Defense through a Medical Technology Enterprise Consortium award to validate Biointellisense’s FDA-cleared Biosticker device for the early detection of COVID-19 symptoms. The goal of the award is to speed the use of wearable diagnostics for to benefit the military and public health through early identification and containment of presymptomatic COVID-19 cases.

Spineway SA, of Ecully, France, said it has chosen TÜV Rheinland as the notified body for certification of its implant and instrument product lines in Europe.

Traction Guest, a Burnaby, British Columbia-based provider of visitor management systems and employee safety tools, has launched a vaccine attestation registry tool for businesses. Available immediately, it enables organizations to incorporate COVID-19 vaccination records into their screening and onsite entry process for workers and visitors.

South San Francisco-based Twist Bioscience Corp. said it plans to expand its manufacturing and commercial capabilities with “factory of the future” in Wilsonville, Ore. The 110,000-square-foot facility is expected to become operational in 2022 and potentially bring up to 400 jobs to the region over several years.

Santa Barbara, Calif.-based World Telehealth Initiative reported an investment from Intel Corp., of Santa Clara, Calif. The investment will be used to expand access to medical care in vulnerable communities around the world, especially amid the COVID-19 pandemic, and further leverage the Purchase, N.Y.-based Teladoc Health’s virtual care enablement platform.

Zuora Inc., an online subscription billing and management platform headquartered in San Mateo, Calif., said it is helping Siemens Healthineers AG, of Erlangen, Germany, introduce new revenue streams from its digital health solutions portfolio using Zuora Billing and Zuora Revenue.